Recently H19 has been shown to be upregulated in paclitaxel-resistant breast cancer cells, and knockdown of H19 might restore chemo-sensitivity in paclitaxel-resistant breast cancer cells [15]. The gene discussed is H19; the disease is breast carcinoma.